High throughput screening News and Research

RSS
High-throughput screening (HTS) allows scientists to test thousands of samples at once. These samples can be of a wide variety, and include, but are not limited to, amino acids, chemical compounds or cells.
New combination technique separates cell types, may prove effective against pathogens

New combination technique separates cell types, may prove effective against pathogens

Researchers develop first plant-based gel to support organoid growth for biomedical applications

Researchers develop first plant-based gel to support organoid growth for biomedical applications

Researchers develop recombinant SARS-CoV-2 model to aid vaccine and antiviral research

Researchers develop recombinant SARS-CoV-2 model to aid vaccine and antiviral research

Ethacridine blocks SARS-CoV-2 with a distinct mode of action

Ethacridine blocks SARS-CoV-2 with a distinct mode of action

Transcriptomics identifies possible COVID-19 therapies

Transcriptomics identifies possible COVID-19 therapies

Small molecules block SARS-CoV-2 spike-ACE2 attachment

Small molecules block SARS-CoV-2 spike-ACE2 attachment

New inhibitor of SARS-CoV-2 RNA translation

New inhibitor of SARS-CoV-2 RNA translation

Eli Lilly's LY-CoV555 antibody shows potential as COVID-19 treatment

Eli Lilly's LY-CoV555 antibody shows potential as COVID-19 treatment

Sanford Burnham Prebys receives NIH grant to identify new therapies for mental disorders

Sanford Burnham Prebys receives NIH grant to identify new therapies for mental disorders

Novel drug candidate offers a major advance in the treatment for diabetes

Novel drug candidate offers a major advance in the treatment for diabetes

High-quality lab procedures crucial to discovery of effective drugs

High-quality lab procedures crucial to discovery of effective drugs

Sanford Burnham Prebys receives CIRM award to advance promising drug candidates for COVID-19

Sanford Burnham Prebys receives CIRM award to advance promising drug candidates for COVID-19

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Small molecule drugs binding Mac1 domain of SARS-CoV-2

Small molecule drugs binding Mac1 domain of SARS-CoV-2

Researchers develop bioprinted skin model of cutaneous squamous cell carcinoma

Researchers develop bioprinted skin model of cutaneous squamous cell carcinoma

Cell 'membrane on a chip' could help test potential drug candidates for COVID-19

Cell 'membrane on a chip' could help test potential drug candidates for COVID-19

New approach holds incredible potential for developing new therapeutics

New approach holds incredible potential for developing new therapeutics

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

G42 and Oxford Nanopore co-develop population-scale technology to detect SARS-CoV-2

G42 and Oxford Nanopore co-develop population-scale technology to detect SARS-CoV-2